Interleukin-21: a double-edged sword with therapeutic potential

R Spolski, WJ Leonard - Nature reviews Drug discovery, 2014 - nature.com
Interleukin-21 is a cytokine with broad pleiotropic actions that affect the differentiation and
function of lymphoid and myeloid cells. Since its discovery in 2000, a tremendous amount …

Death by a thousand cuts: granzyme pathways of programmed cell death

D Chowdhury, J Lieberman - Annu. Rev. Immunol., 2008 - annualreviews.org
The granzymes are cell death–inducing enzymes, stored in the cytotoxic granules of
cytotoxic T lymphocytes and natural killer cells, that are released during granule exocytosis …

An oncolytic virus expressing IL15/IL15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma

R Ma, T Lu, Z Li, KY Teng, AG Mansour, M Yu, L Tian… - Cancer research, 2021 - AACR
IL15 is a pleiotropic cytokine with multiple roles that improve immune responses to tumor
cells. Oncolytic viruses (OV) specifically lyse tumors and activate immune responses …

Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases

M Akdis, S Burgler, R Crameri, T Eiwegger… - Journal of allergy and …, 2011 - Elsevier
Advancing our understanding of mechanisms of immune regulation in allergy, asthma,
autoimmune diseases, tumor development, organ transplantation, and chronic infections …

The common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands

AL Kinter, EJ Godbout, JP McNally, I Sereti… - The Journal of …, 2008 - journals.aai.org
Abstract The programmed death (PD)-1 molecule and its ligands (PD-L1 and PD-L2),
negative regulatory members of the B7 family, play an important role in peripheral tolerance …

Interleukin-21: basic biology and implications for cancer and autoimmunity

R Spolski, WJ Leonard - Annu. Rev. Immunol., 2008 - annualreviews.org
Interleukin-21 (IL-21), a potent immunomodulatory four-α-helical-bundle type I cytokine, is
produced by NKT and CD4+ T cells and has pleiotropic effects on both innate and adaptive …

Emerging strategies in TCR-engineered T cells

F Wei, XX Cheng, JZ Xue, SA Xue - Frontiers in immunology, 2022 - frontiersin.org
Immunotherapy of cancer has made tremendous progress in recent years, as demonstrated
by the remarkable clinical responses obtained from adoptive cell transfer (ACT) of patient …

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes

RB Jones, S Mueller, R O'Connor, K Rimpel… - PLoS …, 2016 - journals.plos.org
Resting CD4+ T-cells harboring inducible HIV proviruses are a critical reservoir in
antiretroviral therapy (ART)-treated subjects. These cells express little to no viral protein, and …

Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis

EW Brenu, ML van Driel, DR Staines, KJ Ashton… - Journal of translational …, 2011 - Springer
Abstract Background Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is
characterised by severe prolonged fatigue, and decreases in cognition and other …

[HTML][HTML] Anti-viral CD8 T cells and the cytokines that they love

MA Cox, SM Kahan, AJ Zajac - Virology, 2013 - Elsevier
Viral infections cause an immunological disequilibrium that provokes CD8 T cell responses.
These cells play critical roles in purging acute infections, limiting persistent infections, and …